97032 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Receptors; Cell surface antigens; Cell surface determinants; Immunoglobulin superfamily CD4
TAG72 TARGETED CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS FOR TREATMENT OF TAG72-POSITIVE TUMORS
#2CD33 TARGETED IMMUNOTHERAPIES
#3ARTICLES OF MANUFACTURE AND METHODS FOR TREATMENT USING ADOPTIVE CELL THERAPY
#4Signalling System
#5GENERATION OF CD4 T CELLS
#6CLL-1 TARGETED IMMUNOTHERAPIES
#7Use of Triplex CMV Vaccine in CAR T Cell Therapy
#8COMPOSITIONS AND METHODS FOR INHIBITION OF FOXP3
#9Administration of Engineered T Cells for Treatment of Cancers in the Central Nervous System
#10CAR-EXPRESSING PLURIPOTENT STEM CELL-DERIVED NEUTROPHILS LOADED WITH DRUG NANOPARTICLES AND USES THEREOF
#11CD6 TARGETED CHIMERIC ANTIGEN RECEPTORS FOR TREATMENT OF CERTAIN AUTOIMMUNE DISORDERS
#12NANOPARTICLE FORMULATIONS
#13MULTIPARTITE RECEPTOR AND SIGNALING COMPLEXES
#14THERAPEUTIC AGENT COMPRISING MULTISPECIFIC ANTIBODY AND USE THEREOF IN TUMOR THERAPY
#15NEW VACCINAL STRATEGY
#16GENETICALLY MODIFIED MICE COMPRISING HUMANIZED CELLULAR IMMUNE SYSTEM COMPONENTS WITH IMPROVED DIVERSITY OF TCRB REPERTOIRE
#17COMPOSITIONS AND METHODS FOR IMMUNOTHERAPY
#18NATURAL KILLER CELLS EXPRESSING DUAL-TARGETING CHIMERIC ANTIGEN RECEPTORS FOR CD19 AND CD22, PRODUCTION METHOD AND USES THEREOF
#19T CELL RECEPTORS TARGETING RAS MUTATIONS AND USES THEREOF
#20CD4 MUTEINS AND METHODS OF USING THE SAME
#21METHODS AND COMPOSITIONS COMPRISING FUSION PROTEINS FOR IMPROVED IMMUNOTHERAPIES
#22METHODS FOR PREPARING CELLS FOR ADOPTIVE T CELL THERAPY
#23IMMUNOTHERAPY WITH B*08 RESTRICTED PEPTIDES AND COMBINATION OF PEPTIDES AGAINST CANCERS AND RELATED METHODS
#24METHODS FOR ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
#25COMPOSITIONS AND METHODS FOR TREATING DISEASE
#26BAFF-R TARGETED CHIMERIC ANTIGEN RECEPTOR-MODIFIED T-CELLS AND USES THEREOF
#27Method of Redirecting T Cells to Treat HIV Infection
#28Chimeric Antigen Receptor-T Cells Targeting HIV-Infected Cells
#29ARTICLES OF MANUFACTURE AND METHODS FOR TREATMENT USING ADOPTIVE CELL THERAPY
#30COMPOUND CHIMERIC ANTIGEN RECEPTOR (CCAR) TARGETING MULTIPLE ANTIGENS, COMPOSITIONS AND METHODS OF USE THEREOF
#31HUMANIZED T CELL CO-RECEPTOR MICE
#32CELLULAR POPULATIONS AND USES THEREOF
#33HIGH SELECTIVE CD229 ANTIGEN BINDING DOMAINS AND METHODS OF USE
#34COMPOSITIONS AND METHODS OF TREATING DISEASE WITH CHIMERIC ANTIGEN RECEPTORS TO B CELL MATURATION ANTIGEN (BCMA)
#35NOVEL CHIMERIC ANTIGEN RECEPTOR AND IMMUNE CELLS EXPRESSING SAME
#36MonoMac-1 Cells Expressing CD16 and CD163
#37MANAbodies AND METHODS OF USING
#38DARIC INTERLEUKIN RECEPTORS
#39NOVEL T CELL RECEPTORS AND IMMUNE THERAPY USING THE SAME
#40ON DEMAND EXPRESSION OF EXOGENOUS FACTORS IN LYMPHOCYTES TO TREAT HIV
#41Modified Chimeric Antigen Receptor and Use thereof
#42FULLY HUMAN ANTIBODY FOR HUMAN B7H3, CHIMERIC ANTIGEN RECEPTOR AND USES THEREOF
#43COMPOSITIONS AND METHODS OF TREATING CANCER WITH CHIMERIC ANTIGEN RECEPTORS TARGETING CLAUDIN 18.2
#44CHIMERIC POLYPEPTIDES, NUCLEIC ACID MOLECULES, CELLS, AND RELATED METHODS
#45ANTIGEN RECOGNIZING RECEPTORS TARGETING CD33 AND USES THEREOF
#46NOVEL CANCER ANTIGENS AND METHODS
#47CHIMERIC ANTIGEN RECEPTOR (CAR) SIGNALING MOLECULES FOR CONTROLLED AND SPECIFIC CAR T CELL ACTIVITY
#48COMPOSITIONS AND METHODS OF TREATING CANCER WITH CHIMERIC ANTIGEN RECEPTORS TARGETING CLAUDIN 18.2
#49ARTICLES OF MANUFACTURE AND METHODS FOR TREATMENT USING ADOPTIVE CELL THERAPY
#50VSIG8-BASED CHIMERIC PROTEINS
#51CHIMERIC TIM4 RECEPTORS AND USES THEREOF
#52MODIFIED HEMATOPOIETIC STEM/PROGENITOR AND NON-T EFFECTOR CELLS, AND USES THEREOF
#53DIMERIZING AGENT REGULATED IMMUNORECEPTOR COMPLEXES
#54CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF
#55DIMERIZING AGENT REGULATED IMMUNORECEPTOR COMPLEXES
#56Use of Triplex CMV Vaccine in CAR T Cell Therapy
#57Methods for Preparing Genetically Modified Cells
#58METHODS AND COMPOSITIONS FOR CELLULAR IMMUNOTHERAPY
#59BIOORTHOGONAL REPORTER GENE SYSTEM
#60DOWNREGULATION OF MEMBRANE-BOUND PROTEINS BY RECEPTOR TAC TECHNOLOGY
#61CHIMERIC ANTIGEN RECEPTORS SPECIFIC FOR P95HER2 AND USES THEREOF
#62CHIMERIC ANTIGEN RECEPTORS TARGETED TO PSCA
#63PROGRAMMING OF REGULATORY T CELLS BY EXTRACELLULAR VESICLES
#64METHODS OF GENERATING AN ACTIVATION INDUCIBLE EXPRESSION SYSTEM IN IMMUNE CELLS
#65COMPOSITIONS AND USES OF CD45 TARGETED CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS
#66CELLULAR POPULATIONS AND USES THEREOF
#67T CELLS AND CHIMERIC STIMULATING RECEPTORS AND USES THEREOF
#68MULTIPARTITE SIGNALING PROTEINS AND USES THEREOF
#69CHIMERIC ANTIGEN RECEPTOR AND USE THEREOF
#70Armed Dual CAR-T Compositions and Methods For Cancer Immunotherapy
#71T cell-antigen coupler with Y182T mutation and methods of uses thereof
#72CHIMERIC ANTIGEN RECEPTOR CONSTRUCTS AND THEIR USE IN CAR-T CELLS
#73CHIMERIC ANTIGEN RECEPTOR FOR TREATMENT OF CANCER
#74ANTIBODIES SPECIFIC FOR CD22 AND USES THEREOF
#75TRIFUNCTIONAL T CELL-ANTIGEN COUPLER AND METHODS AND USES THEREOF
#76T cell-antigen coupler with various construct optimizations
#77ALTERNATIVE GENERATION OF ALLOGENEIC HUMAN T CELLS
#78Memory Dimeric Antigen Receptors (mDARs)
#79CD4 muteins and methods of using the same
#80CORONAVIRUS VACCINE
#81Articles of manufacture and methods for treatment using adoptive cell therapy
#82T CELL RECEPTORS RECOGNIZING MHC CLASS II-RESTRICTED MAGE-A3
#83DIMERIZING AGENT REGULATED IMMUNORECEPTOR COMPLEXES
#84FC-FUSION PROTEIN DERIVATIVES WITH HIGH DUAL HIV ANTIVIRAL AND IMMUNOMODULATORY ACTIVITY
#85B-CELL ANTIBODY RECEPTOR AND USE THEREOF
#86CHIMERIC RECEPTOR PROTEINS AND USES THEREOF
#87Compositions and Methods for Treating Cancer with Anti-ROR1 Immunotherapy
#88ENGINEERED T CELL RECEPTORS AND USES THEREOF
#89CHIMERIC ANTIGEN RECEPTOR COMPRISING ANTI C-MET ANTIBODY OR ANTIGEN BINDING FRAGMENT THEREOF, AND USE THEREOF
#90COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS
#91TRIFUNCTIONAL T CELL-ANTIGEN COUPLER AND METHODS AND USES THEREOF
#92CD33 TARGETED IMMUNOTHERAPIES
#93CLL-1 TARGETED IMMUNOTHERAPIES
#94GENETICALLY MODIFIED MICE COMPRISING HUMANIZED CELLULAR IMMUNE SYSTEM COMPONENTS WITH IMPROVED DIVERSITY OF TCRB REPERTOIRE
#95ANTI-L1CAM ANTIBODY OR ANTIGEN-BINDING FRAGMENT THEREOF AND CHIMERIC ANTIGEN RECEPTOR COMPRISING SAME
#96Modified NK-92 cells, and therapeutic and diagnostic uses thereof
#97ENHANCEMENT OF POLYPEPTIDES AND CHIMERIC ANTIGEN RECEPTORS VIA HINGE DOMAINS
#98GENETICALLY MODIFIED MAJOR HISTOCOMPATIBILITY COMPLEX MICE
#99CHIMERIC ANTIGEN RECEPTORS CONTAINING A CHLOROTOXIN DOMAIN
#100Compositions and methods for immunotherapy
#101Armed dual CAR-T compositions and methods for cancer immunotherapy
#102CHIMERIC ANTIGEN RECEPTOR (CAR) NK CELLS AND USES THEREOF
#103VSIG8-based chimeric proteins
#104METHOD AND COMPOSITION FOR PREDICTING LONG-TERM SURVIVAL IN CANCER IMMUNOTHERAPY
#105NANOPARTICLE FORMULATIONS
#106Protein M fusion proteins and uses
#107TREATMENT METHOD FOR PSORIASIS
#108COMBINATION THERAPY COMPRISING CANCER-TARGETED CAR-T CELLS AND A METHOD OF USING SAME FOR A TREATMENT FOR CANCER
#109METHODS AND COMPOSITIONS FOR ENGINEERING CD4-DEFICIENT CAR T CELLS AND ANTI-CD4 CAR T CELLS AND USES THEREOF
#110METHODS AND COMPOSITONS FOR MODULATIONS OF IMMUNE RESPONSE
#111Dimerizing agent regulated immunoreceptor complexes
#112BAFF-R targeted chimeric antigen receptor-modified T-cells and uses thereof
#113Immunotherapy with B*08 restricted peptides and combination of peptides against cancers and related methods
#114Immunotherapy with B*08 restricted peptides and combination of peptides against cancers and related methods
#115Recombinant viral vector, immune composition containing same, and use thereof
#116CD6 targeted chimeric antigen receptors for treatment of certain autoimmune disorders
#117CoV-2 (CoV-n) antibody neutralizing and CTL vaccines using protein scaffolds and molecular evolution
#118CHIMERIC MOLECULES
#119METHODS AND COMPOSITIONS FOR STIMULATION OF CHIMERIC ANTIGEN RECEPTOR T CELLS WITH HAPTEN LABELLED CELLS
#120TAG72 targeted chimeric antigen receptor modified T cells for treatment of TAG72-positive tumors
#121USE OF INTERLEUKIN-7 AND CHIMERIC ANTIGEN RECEPTOR (CAR)-BEARING IMMUNE EFFECTOR CELLS FOR TREATING TUMOR
#122T cell-antigen coupler with Y177 mutation and methods of uses thereof
#123ENHANCED PRODUCTION OF IMMUNOGLOBULINS
#124CHIMERIC RECEPTORS TO STEAP1 AND METHODS OF USE THEREOF
#125Administration of Engineered T Cells for Treatment of Cancers in the Central Nervous System
#126HIV antibody derivatives with dual antiviral and immunomodulatory activities from CD4 and GP41
#127INDUCTION OF ANTI-TUMORAL IMMUNE MICROENVIRONMENTS
#128NKG2D DARIC RECEPTORS
#129IL-13/IL-4 SUPERKINES: IMMUNE CELL TARGETING CONSTRUCTS AND METHODS OF USE THEREOF
#130Methods and compositions for cellular immunotherapy
#131Generating HPV antigen-specific cells from a naive T cell population
#132Generating HPV antigen-specific cells from a naive T cell population
#133Vaccinal strategy
#134Trifunctional T cell-antigen coupler and methods and uses thereof
#135Compositions and methods for the isolation and/or generation of specific CD4+ and CD8+ T-cell subsets
#136Use of Triplex CMV Vaccine in CAR T Cell Therapy
#137METHOD OF TREATING IMMUNOTHERAPY NON-RESPONDERS WITH AN AUTOLOGOUS CELL THERAPY
#138METHODS FOR PREPARING CELLS FOR ADOPTIVE T CELL THERAPY
#139COMPOSITIONS AND METHODS FOR INHIBITION OF FOXP3
#140Humanized T cell co-receptor mice
#141SIGNALLING SYSTEM
#142BISPECIFIC CHIMERIC ANTIGEN RECEPTORS AND THEIR APPLICATION IN THE TREATMENT OF TUMOR
#143METHOD FOR ANTI-MUC1* CAR T CELL STIMULATION
#144CYCLIN A1 SPECIFIC T CELL RECEPTORS AND USES THEREOF
#145T cell-antigen coupler with Y182T mutation and methods and uses thereof
#146Dimerizing agent regulated immunoreceptor complexes comprising interleukin receptor signaling domains
#147Method of treating a tumor in a patient based on an immune gene expression
#148DUAL CAR EXPRESSING T CELLS INDIVIDUALLY LINKED TO CD28 AND 4-1BB
#149METHODS FOR IDENTIFYING AND SEPARATING PRO-ALLERGIC SPECIFIC T CELLS
#150Method of redirecting t cells to treat HIV infection
#151Chimeric immunoreceptor useful in treating human cancers
#152COSTIMULATORY CHIMERIC ANTIGEN RECEPTOR T CELLS TARGETING IL13R-alpha-2
#153Compound chimeric antigen receptor (cCAR) targeting multiple antigens, compositions and methods of use thereof
#154Chimeric antigen receptors targeted to PSCA
#155T cell-antigen coupler with various construct optimizations
#156Trifunctional T cell-antigen coupler and methods and uses thereof
#157T CELL RECEPTORS RECOGNIZING MHC CLASS II-RESTRICTED MAGE-A3
#158T cell receptors and immune therapy using the same
#159T cell-antigen coupler with various construct optimizations
#160Nanoparticle formulations
#161Fusion peptides of CD4 helper T cell epitopes and vaccines thereof
#162T cell compositions with improved phenotypic properties
#163Immunotherapy with b*08 restricted peptides and combination of peptides against cancers and related methods
#164T CELL COMPOSITIONS WITH IMPROVED PHENOTYPIC PROPERTIES
#165CS1 targeted chimeric antigen receptor-modified T cells for treatment of AL amyloidosis
#166Methods and compositions for protection against lentiviral infections
#167HERPES SIMPLEX VIRUS VACCINE EPITOPES SPECIFICALLY RECOGNIZED BY TISSUE RESIDENT MEMORY T CELLS
#168FC-FUSION PROTEIN DERIVATIVES WITH HIGH DUAL HIV ANTIVIRAL AND IMMUNOMODULATORY ACTIVITY
#169Cellular populations and uses thereof
#170Articles of manufacture and methods for treatment using adoptive cell therapy
#171SELECTABLE STEM CELL MODIFICATION FOR GENE THERAPY USING TRANSIENT CELL SURFACE MARKING OF MODIFIED CELLS USING MODIFIED CD4 MOLECULE
#172Methods and compositions for promoting immune cell function
#173CHIMERIC ANTIGEN AND T CELL RECEPTORS AND METHODS OF USE
#174Method for the detection, preparation and depletion of CD4+ t lymphocytes
#175Compositions and methods for treating cancer with anti-ROR1 immunotherapy
#176MANAbodies and methods of using
#177Multipartite signaling proteins and uses thereof
#178MULTIPARTITE SIGNALING PROTEINS AND USES THEREOF
#179VSIG8-based chimeric proteins
#180Trifunctional T cell-antigen coupler and methods and uses thereof
#181Protective Chimeric Antigen Receptor Stem Cell Gene Therapy for Viral Infection
#182Cell
#183T cell-antigen coupler with various construct optimizations
#184MonoMac-1 cells expressing CD16 and CD163
#185IMMUNE CELL COMPOSITIONS AND METHODS OF USE
#186Chimeric antigen receptors containing a chlorotoxin domain
#187MODIFIED HEMATOPOIETIC STEM/PROGENITOR AND NON-T EFFECTOR CELLS, AND USES THEREOF
#188VSIG8-based chimeric proteins
#189ASPARTATE BETA-HYDROXYLASE CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF
#190Signalling system
#191T cell receptors and immune therapy using the same
#192SIGNAL TRANSDUCTION MODIFYING PROTEIN
#193BAFF-R targeted chimeric antigen receptor-modified t-cells and uses thereof
#194Use of Triplex CMV Vaccine in CAR T Cell Therapy
#195Slit2D2-chimeric antigen receptor and application thereof
#196Transgenic VERO-CD4/CCR5 cell line
#197ANTI-OSTEOSARCOMA CAR-T DERIVED FROM THE ANTIBODY OI-3
#198Anti-CD7 chimeric antigen receptor and method of use thereof
#199Genetically modified major histocompatibility complex mice
#200Multipartite signaling proteins and uses thereof
#201COMPOSITIONS, METHODS, AND COMPUTER SYSTEMS RELATED TO MAKING AND ADMINISTERING MODIFIED T CELLS
#202Compositions and methods for treating cancer with anti-ROR1 immunotherapy
#203Methods and compositions for cellular immunotherapy
#204METHODS FOR PREPARING CELLS FOR ADOPTIVE T CELL THERAPY
#205CHIMERIC RECEPTORS CONTAINING TRAF-INDUCING DOMAINS AND RELATED COMPOSITIONS AND METHODS
#206Generating HPV antigen-specific cells from a naive T cell population
#207Engineering Antiviral T Cell Immunity through Stem Cells and Chimeric Antigen Receptors
#208CD8a and t cell receptor variants and methods of using same in modulating immune cell responses
#209Costimulatory chimeric antigen receptor T cells targeting IL13Rα2
#210Method of redirecting T cells to treat HIV infection
#211POLYPEPTIDES COMPRISING A MODIFIED BACTERIOPHAGE G3P AMINO ACID SEQUENCE WITH REDUCED IMMUNOGENICITY
#212LIGHT-ACTIVATED, CALCIUM-GATED POLYPEPTIDE AND METHODS OF USE THEREOF
#213METHODS AND COMPOSITIONS FOR TREATING HIV
#214T cell receptors and immune therapy using the same
#215Nanoparticle formulations
#216T cell receptors recognizing MHC class II-restricted MAGE-A3
#217Bispecific multivalent fusion proteins
#218Genetically modified major histocompatibility complex mice
#219Stabilized single human CD4 domains and fusion proteins
#220Humanized T cell co-receptor mice
#221Chimeric antigen receptor signalling system comprising heterodimerization domains
#222Conjugated molecules comprising a peptide derived from the CD4 receptor coupled to an anionic polypeptide for the treatment of AIDS
#223NOVEL CHIMERIC ANTIGEN RECEPTORS
#224Chimeric antigen and T cell receptors and methods of use
#225Chimeric antigen receptors to control HIV infection
#226Transgenic Vero-CD4/CCR5 cell line
#227Signalling system
#228Production of recombinant expression vectors
#229Enhanced production of immunoglobulins
#230COMPOSITIONS, METHODS, AND COMPUTER SYSTEMS RELATED TO MAKING AND ADMINISTERING MODIFIED T CELLS
#231Chimeric Immunoreceptor Useful in Treating Human Cancers
#232POLYPEPTIDES COMPRISING A MODIFIED BACTERIOPHAGE G3P AMINO ACID SEQUENCE WITH REDUCED IMMUNOGENICITY
#233Methods for identifying and isolating cells expressing a polypeptide
#234Trifunctional T cell-antigen coupler and methods and uses thereof
#235Costimulatory chimeric antigen receptor T cells targeting IL13Rα2
#236Methods and compositions for protection against lentiviral infections
#237Multipartite signaling proteins and uses thereof
#238MODIFIED HEMATOPOIETIC STEM/PROGENITOR AND NON-T EFFECTOR CELLS, AND USES THEREOF
#239Anti-HIV domain antibodies and method of making and using same
#240ONCOLOGY VACCINE
#241Engineering antiviral T cell immunity through stem cells and chimeric antigen receptors
#242Chimeric Immunoreceptor Useful in Treating Human Cancers
#243Polypeptides comprising a modified bacteriophage g3p amino acid sequence with reduced immunogenicity
#244STABILIZED SINGLE HUMAN CD4 DOMAINS AND FUSION PROTEINS
#245Compositions and methods for immunotherapy
#246Methods for identifying and isolating cells expressing a polypeptide
#247Multipartite signaling proteins and uses thereof
#248T cell receptors recognizing MHC class II-restricted MAGE-A3
#249Genetically modified major histocompatibility complex mice
#250Humanized T cell co-receptor mice
#251Conjugated molecules comprising a peptide derived from the CD4 receptor coupled to a polyanionic polypeptide for the treatment of AIDS
#252Glycosylated specificity exchangers
#253Methods for identifying and isolating cells expressing a polypeptide
#254Methods for identifying and isolating cells expressing a polypeptide
#255Methods and compositions for treating HIV
#256BIVALENT MOLECULES FOR HIV ENTRY INHIBITION
#257METHOD AND SYSTEM FOR MAPPING SYNAPTIC CONNECTIVITY USING LIGHT MICROSCOPY
#258Glycosylated specificity exchangers
#259Conformationally stabilized HIV envelope immunogens
#260Chimeric immunoreceptor useful in treating human cancers
#261ENV POLYPEPTIDE COMPLEXES AND METHODS OF USE
#262Method of inducing an antiviral immune response against HIV-1 utilizing chimeric HIV Env proteins comprising CD4 mini-proteins or CD4 mimetics
#263Pharmaceutical composition and methods of treating and preventing the diseases caused by HIV or associated with HIV
#264Method of generating an immune response in a subject using fusion proteins comprising CD4 minimal modules and HIV Tat scaffold polypeptides that are capable of binding to the HIV envelope and exposing cryptic neutralization epitopes
#265Method for generating immune responses utilizing nucleic acids encoding fusion proteins comprising CD4 minimal modules and invasin polypeptides that are capable of binding to the HIV envelope and exposing cryptic neutralization epitopes
#266Methods and compositions for inhibiting viral entry into cells
#267Conformationally stabilized HIV envelope immunogens
#268Anticoagulant fusion protein anchored to cell membrane
#269PROTEIN PARTICLES
#270NUCLEIC ACID ENCODING FUSION POLYPEPTIDES THAT PREVENT OR INHIBIT HIV INFECTION
#271Methods for identifying and isolating cells expressing a polypeptide
#272Bifunctional molecules for inactivating HIV and blocking HIV entry
#273Method of diagnosis and kit therefor
#274Chimeric immunoreceptor useful in treating human gliomas
#275Conjugated molecules comprising a peptide derived from the CD4 receptor coupled to a polyanion for the treatment of AIDS
#276Anti-HIV domain antibodies and method of making and using same
#277Anti-viral fusion peptides
#278Chimeric HIV Env proteins comprising CD4 mini-proteins or CD4 mimetics that are capable of inducing neutralizing antibody responses against cryptic Env epitopes
#279CD4-RECEPTOR-DERIVED PEPTIDES AND METHOD FOR THE PREPARATION THEREOF
#280Compositions and methods of tolerizing a primate to an antigen
#281Knobs and holes heteromeric polypeptides
#282Fusion proteins comprising CD4 minimal modules and invasin polypeptides that are capable of binding to the HIV envelope and exposing cryptic neutraliziation epitopes
#283Glycosylated specificity exchangers
#284Muteins of tear lipocalin with affinity for the T-cell coreceptor CD4
#285VACCINE COMPOSITIONS AGAINST INFECTIOUS PATHOLOGIES FOR MAMMALS
#286GLYCOSYLATED SPECIFICITY EXCHANGER
#287IMMUNOCONJUGATES COMPRISING CD4 AND IMMUNOGLOBIN MOLECULES FOR THE TREATMENT OF HIV INFECTION
#288CD4 mimic peptides and their uses
#289Chimeric immunoreceptor useful in treating human cancers
#290Chemically Derivatized CD4 and Uses Thereof
#291Conformationally stabilized HIV envelope immunogens and triggering HIV-I envelope to reveal cryptic V3-loop epitopes
#292Scientifically Modulated And Reprogrammed Treatment (SMART) Virus Technology Intended to Neutralize the Human Immunodeficiency Virus
#293Hiv Gp120 Crystal Structure and Its Use to Identify Immunogens
#294GLYCOSYLATED SPECIFICITY EXCHANGERS THAT INDUCE AN ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY (ADCC) RESPONSE
#295Virus coat protein/receptor chimeras and methods of use
#296Fusion proteins comprising CD4 minimal modules and human immunodeficiency virus (HIV) Tat scaffold polypeptides that are capable of binding to the HIV envelope and exposing cryptic neutralization epitopes
#297Compositions and Methods for Preventing or Treating Hiv Infection
#298Inhibitors of viral entry screening method
#299Immunogen
#300Env polypeptide complexes and methods of use